Aug 2026 (Q2 FY27) — Oct 14, 2026
Sono-Tek Q2 FY27 — Strong Medical Growth and Record Backlog Drive FY28 Visibility
Read the full callSono TEK (SOTK) earnings
- Aug 2026
- Aug 2026 (Q2 FY27)
- Feb 2026
Sono TEK earnings: last reported Wed, 14 Oct 2026, for the quarter ended Aug 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 5.2 | +1.3% YoY | Quarterly, as filed | Quarter to Aug 2026 | Revenue from operations as filed. |
| Operating margin | 7.3 | −0.9 pts YoY | Operating profit / revenue | Quarter to Aug 2026 | For the quarter; a change is in percentage points. |
| Net profit | 0.37 | −13.5% YoY | Quarterly, as filed | Quarter to Aug 2026 | Profit after tax as filed. |
Price
$5.47 −11.20% · −$0.69
Performance +31.8% 1Y
1Y: $4.15 on 17 Oct 2025 → $5.47. High $7.16 (12 Oct 2026), low $3.6 (15 Dec 2025).
- Previous close
- $6.16
- 52-week range
- $3.6 – $7.16
- One year
- +33.09%
Overview
- Symbol
- SOTK
- Sector
- Industrials
- Exchange
- US
- Currency
- USD
Call summaries
Feb 2026 (Q4 FY26) — May 28, 2026
Sono-Tek Q4 FY26 — Strong Profitability Expansion Driven by High-Value Systems
Read the full callEvery analysed call
Sono TEK earnings calls (SOTK)
Financials
What the filings say
Net profit, year on year: −14% (quarter to aug 2026 against aug 2025).
| Line item | Nov 2024 | Feb 2025 | May 2025 | Aug 2025 | Nov 2025 | Feb 2026 | May 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 5 |
| Operating profit | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Operating margin | 3.8% | 5.6% | 9.4% | 8.2% | 6.4% | 10.7% | 15.8% | 7.3% |
| Net profit | 0 | — | 0 | 0 | 0 | — | 1 | 0 |
| EPS ($ per share) | 0.02 | — | 0.03 | 0.03 | 0.02 | — | 0.05 | 0.02 |
| Line item | Feb 2019 | Feb 2020 | Feb 2021 | Feb 2022 | Feb 2023 | Feb 2024 | Feb 2025 | Feb 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -0 | 1 | 2 | 4 | 5 | 6 | 8 | 9 |
| Total liabilities | 4 | 5 | 5 | 4 | 6 | 7 | 6 | 7 |
| Fixed assets | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
| Investments | 2 | 4 | 5 | 6 | 8 | 10 | 7 | 7 |
| Total assets | 12 | 15 | 16 | 18 | 20 | 23 | 23 | 26 |
| Line item | Feb 2019 | Feb 2020 | Feb 2021 | Feb 2022 | Feb 2023 | Feb 2024 | Feb 2025 | Feb 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -0 | 3 | 1 | 2 | 1 | 1 | 1 | 3 |
| Cash from investing | 1 | -3 | -1 | -2 | -3 | -2 | 3 | -1 |
| Cash from financing | -0 | -0 | 0 | 0 | — | — | -0 | -0 |
| Net cash flow | — | 1 | 0 | 1 | -1 | -1 | 3 | 2 |
| Capital expenditure | -1 | -1 | -0 | -0 | -1 | -1 | -0 | -0 |
| Free cash flow | -1 | 3 | 0 | 2 | 1 | 0 | 0 | 3 |
SOTK operating KPIs by quarter
| KPI | Feb 2026 Q4 FY26 | Aug 2026 Q2 FY27 | Change vs prior quarter |
|---|---|---|---|
| Backlog | ~$9.12MWe ended fiscal year 2026 with a backlog of approximately $9.12 million, and that's remaining pretty close to historically high levels, and that is supporting our visibility into fiscal 2027.Source: earnings call transcript | ~$9.5MOn August 31, our backlog was approximately 9.5 million, and that's up 23% from the end of the fiscal quarter.Source: earnings call transcript | — |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Insider filings
45 filings between Oct 21, 2025 and Oct 14, 2026.
Open market
decisions to buy or sellPurchases
$9.9K
1 purchase by 1 insider
Sales
$238.0K
9 sales by 2 insiders
56% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 19
- Option exercise — converted options into shares
- 16
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| COCCIO CHRISTOPHER L | — | $170.3K | Jul 21, 2026 |
| Bagley Stephen James | — | $67.7K | Jul 30, 2026 |
| Lawal Adeniyi | $9.9K | — | Mar 5, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 14, 2026 | Kuha Maria T VP | Option exercise | 5,488 | $17.8K |
| Oct 14, 2026 | Kuha Maria T VP | Tax withheld | 4,468 | $31.8K |
| Oct 14, 2026 | Kuha Maria T VP | Option exercise | 7,722 | $31.8K |
| Oct 14, 2026 | Kuha Maria T VP | Tax withheld | 1,031 | $7.3K |
| Oct 14, 2026 | Kuha Maria T VP | Option exercise | 1,650 | $7.3K |
| Oct 14, 2026 | Kuha Maria T VP | Tax withheld | 2,506 | $17.8K |
| Oct 12, 2026 | RIEMER JOSEPH Director | Tax withheld | 749 | $5.3K |
| Oct 12, 2026 | RIEMER JOSEPH Director | Option exercise | 2,000 | $5.3K |
| Oct 12, 2026 | Bagley Stephen James CFO | Tax withheld | 4,494 | $31.8K |
| Oct 12, 2026 | Bagley Stephen James CFO | Option exercise | 7,722 | $31.8K |
| Oct 12, 2026 | RIEMER JOSEPH Director | Option exercise | 3,158 | $10.3K |
| Oct 12, 2026 | RIEMER JOSEPH Director | Tax withheld | 2,483 | $17.6K |
| Oct 12, 2026 | RIEMER JOSEPH Director | Option exercise | 4,267 | $17.6K |
| Oct 12, 2026 | RIEMER JOSEPH Director | Tax withheld | 1,450 | $10.3K |
| Oct 12, 2026 | RIEMER JOSEPH Director | Tax withheld | 2,487 | $17.6K |
| Oct 12, 2026 | RIEMER JOSEPH Director | Option exercise | 3,676 | $17.6K |
| Oct 12, 2026 | RIEMER JOSEPH Director | Tax withheld | 736 | $5.2K |
| Oct 12, 2026 | RIEMER JOSEPH Director | Option exercise | 3,300 | $18.1K |
| Oct 12, 2026 | RIEMER JOSEPH Director | Tax withheld | 2,726 | $19.3K |
| Oct 12, 2026 | RIEMER JOSEPH Director | Option exercise | 6,050 | $19.3K |
| Oct 8, 2026 | Cichetti Christopher COO | Tax withheld | 4,804 | $32.4K |
| Oct 8, 2026 | Cichetti Christopher COO | Option exercise | 9,978 | $32.4K |
| Oct 6, 2026 | HARSHBARGER R STEPHEN CEO | Option exercise | 13,171 | $42.8K |
| Oct 6, 2026 | HARSHBARGER R STEPHEN CEO | Tax withheld | 6,286 | $42.8K |
| Oct 6, 2026 | Booth Brian Lewis Vice President | Option exercise | 3,293 | $10.7K |
| Oct 6, 2026 | Booth Brian Lewis Vice President | Tax withheld | 1,572 | $10.7K |
| Oct 6, 2026 | Booth Brian Lewis Vice President | Option exercise | 2,027 | $8.4K |
| Oct 6, 2026 | Booth Brian Lewis Vice President | Tax withheld | 1,226 | $8.3K |
| Oct 5, 2026 | COCCIO CHRISTOPHER L Director | Option exercise | 13,158 | $42.8K |
| Oct 5, 2026 | Bagley Stephen James CFO | Option exercise | 5,488 | $17.8K |
| Oct 5, 2026 | Bagley Stephen James CFO | Tax withheld | 2,877 | $17.8K |
| Oct 5, 2026 | COCCIO CHRISTOPHER L Director | Tax withheld | 6,897 | $42.8K |
| Jul 30, 2026 | Bagley Stephen James CFO | Sale | 8,346 | $42.8K |
| Jul 27, 2026 | Bagley Stephen James CFO | Sale | 1,200 | $6.1K |
| Jul 23, 2026 | Bagley Stephen James CFO | Sale | 3,454 | $18.8K |
| Jul 21, 2026 | COCCIO CHRISTOPHER L Director | Sale | 17,000 | $91.4K |
| May 1, 2026 | Booth Brian Lewis Vice President | Option exercise | 3,299 | $18.1K |
| May 1, 2026 | Booth Brian Lewis Vice President | Option exercise | 2,606 | $10.7K |
| May 1, 2026 | Booth Brian Lewis Vice President | Option exercise | 1,650 | $7.3K |
| Mar 5, 2026 | Lawal Adeniyi Director | Purchase | 2,400 | $9.9K |
| Oct 23, 2025 | COCCIO CHRISTOPHER L Director | Sale 10b5-1 plan | 12,320 | $58.9K |
| Oct 21, 2025 | COCCIO CHRISTOPHER L Director | Sale 10b5-1 plan | 100 | $467 |
| Oct 21, 2025 | COCCIO CHRISTOPHER L Director | Sale 10b5-1 plan | 2,015 | $9.4K |
| Oct 21, 2025 | COCCIO CHRISTOPHER L Director | Sale 10b5-1 plan | 2,097 | $9.8K |
| Oct 21, 2025 | COCCIO CHRISTOPHER L Director | Sale 10b5-1 plan | 100 | $467 |
| Aug 19, 2025 | Bagley Stephen James CFO | Sale | 299 | $999 |
| Aug 18, 2025 | Bagley Stephen James CFO | Sale | 295 | $988 |
| Aug 18, 2025 | Bagley Stephen James CFO | Sale | 301 | $1.0K |
| Aug 18, 2025 | Bagley Stephen James CFO | Sale | 998 | $3.4K |
| Aug 7, 2025 | Bagley Stephen James CFO | Sale | 350 | $1.2K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for SONO TEK CORP
Free account. Everything above stays public.
Write why you follow SONO TEK CORP and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading